Search
for
Sort by
Research 451–480 of 1000+
- Diffusion properties of model compounds in artificial sebum
- Current management of androgenetic alopecia in men.
- Mesotherapy: From Historical Notes to Scientific Evidence and Future Prospects
- Transdermal Liposomal Delivery Systems: Advantages, Applications, Challenges, and Prospects
- Topical delivery of nanoemulsions for skin cancer treatment
- Targeting the Complexity of In Vitro Skin Models: A Review of Cutting-Edge Developments
- Research-based findings on scope of liposome-based cosmeceuticals: an updated review
- New potential antiscarring approaches
- Dissolving microneedle array patches containing mesoporous silica nanoparticles of different pore sizes as a tunable sustained release platform
- Bioinspired Polymers: Transformative Applications in Biomedicine and Regenerative Medicine
- Advances of Microneedles for Cancer Diagnosis and Therapy
- A guide to diagnosis and management of hypertrichosis
- Quantitation of Hepatitis C Virus RNA
- Psoriasis
- Stimuli-Sensitive Nanocarriers for Diagnostic and Therapy
- Homology Modeling of 5-alpha-Reductase 2 Using Available Experimental Data
- QbD based Formulation for Liposomal Combination of AdapaleneClindamycin with Gel Matrix for Enhanced Acne Treatment
- Science and peace
- Psychological interventions in the management of common skin conditions
- Update on psychodermatological disorders
- Nanotechnology Approaches in Chronic Wound Healing
- Androgenetic Alopecia: An Update of Treatment Options
- Animal models of psoriasis—highlights and drawbacks
- Chemotherapy‐induced alopecia management: Clinical experience and practical advice
- Small Molecule Wnt Pathway Modulators from Natural Sources: History, State of the Art and Perspectives
- ADVANCES IN PSORIASIS THERAPY
- Phytochemical, Toxicological and Pharmacological Studies of <i>Asiasari Radix</i> et Rhizoma: A Review
- Hydrogel-Based Strategies for the Prevention and Treatment of Radiation-Induced Skin Injury: Progress and Mechanistic Insights
- Erythroderma: clinical and etiological study of 88 cases seen in a tertiary hospital over 25 years
- A Case of Tofacitinib for the Treatment of Resistant Vitiligo and Sustained Repigmentation After Discontinuation